Home-based UVB narrowband phototherapy is considered safe and well established for conditions such as psoriasis, eczema and vitiligo when a CE MDR–marked medical device is used with correct dosing, appropriate guidance and adherence to instructions.
When considering treatment at home, only CE MDR–certified medical devices should be used. There is an important difference between medical-grade home devices and commercial sunlamps: unregulated sunlamps are not recommended, as they are not standardised, may be less effective, and can pose safety risks.
Home UV treatment is safe for many people, but some conditions — such as photosensitivity disorders or previous skin cancer — may mean it is not appropriate. Medical advice should always be sought before starting treatment.
However, not all medical UVB lamps offer the same level of safety. While CE MDR (Class IIa) certification confirms compliance with strict medical safety standards, UV Tactus is designed to go beyond standard requirements. Moreover, UV Tactus medical device is certified under the EU Medical Device Regulation (MDR 2017/745), the latest and most stringent medical device regulatory frameworks, ensuring highest standards of safety and performance.
To maximise safety at home, UV Tactus is equipped with additional advanced features not found in other devices:
uses an integrated dosimeter to measure the therapeutic UVB narrowband dose in Joules in real time, delivering the same accuracy as in-clinic. UK dermatology guidelines emphasise that accurate dose delivery (dosimetry) is critical for both the safety and effectiveness of UVB treatment¹;
automatically shuts off once the prescribed dose is reached and is password-protected;
has silicone applicators that help shield surrounding healthy skin from UV exposure;
has a treatment window that may be divided into smaller zones that allow precise, localised exposure only where needed;
is fully digital and requires confirmation for key actions, reducing the risk of accidental misuse and making it intuitive and easy to use.
The companion app further supports safe and consistent treatment by calculating doses based on treatment protocol and instructions, guiding each session step by step, and sending reminders to support adherence.
Why this matters: these combined UV Tactus safeguards reduce guesswork, minimise the risk of over or underexposure, and help deliver clinic-level treatment safely and effectively in the comfort of your home.
- ¹ British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022